The results were announced during trading hours today, 31 January 2008.
Meanwhile, BSE Sensex was down 143.91 points or 0.81% to 17,614.73.
On BSE, 6,725 shares were traded in the counter. The scrip had an average daily volume of 19,719 shares in the past one quarter.
The stock hit a high of Rs 260 and a low of Rs 248.05 so far during the day. The stock had a 52-week high of Rs 411.70 on 21 June 2007 and a 52-week low of Rs 202.50 on 22 January 2008.
The mid-cap scrip had underperformed the market over the past one month 30 January 2008, declining 18.77% compared to the Sensex`s decline of 12.52%. It had also underperformed the market in the past one quarter, declining 18.57% compared to Sensex`s decline of 9.97%.
The company`s current equity is Rs 62.80 crore. Face value per share is Rs 5.
The current price of Rs 249 discounts its Q2 September 2007 annualized EPS of Rs 22.71, by a PE multiple of 10.96.
Cadila Healthcare`s total income rose 18.7% to Rs 453.9 crore in Q3 December 2007 over Q3 December 2006.
Cadila Healthcare is the flagship of Zydus Cadila Group. The company`s operations include pharmaceuticals (human formulations, veterinary formulations and bulk drugs), diagnostics, herbal products, skin care products and OTC products.
No comments:
Post a Comment